Tumay Ak (2024) “Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study”, Archives of Rheumatology, 39(1), pp. 071–080. doi: 10.46497/ArchRheumatol.2024.10050.